Heart Health, Inc. Researches Predicate Devices to Accelerate FDA Approval of Heart Health Monitor

MONTREAL, CANADA--(Marketwire - April 03, 2008) - Heart Health, Inc. (OTCPK: HHEA) is pleased to announce that the Company is currently researching similar products to receive approval of its Heart Health Monitor (HHM). Selection of a similar product, known as “Predicate Device,” will enable the Company to proceed in filing its 510(k) to the FDA, which will allow Heart Health to begin marketing the HHM to the public.